FARXIGA is a prescription medicine used to improve blood sugar control along with diet and exercise in adults with type 2 diabetes, and to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and known cardiovascular disease (CV) or multiple CV risk factors. It is also used to reduce the risk of CV death and hospitalization for heart failure in adults with heart failure (when the heart is weak and cannot pump enough blood to the rest of your body). See more.
YOU ARE ABOUT TO LEAVE THE FARXIGA WEB SITE.
AstraZeneca does not review the information on this Web site and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and coniditions set by the Web site and/or database producer.
AstraZencea makes no representation as to the accuracy or any other aspect of the information contained on such Web site and/or database, nor does AstraZeneca endorse such Web site and/or database.
Thank you for visiting the website
This link will take you to another web site. AstraZeneca provides this link as a service to site visitors. AstraZeneca is not responsible for the privacy policies of third party websites. We encourage you to read the policy of each website you visit.Do you wish to continue?